Skip to main content

Table 1 Characteristics of the study patients according to infection status.

From: Assessment of candidemia-attributable mortality in critically ill patients using propensity score matching analysis

 

Without candidemia

(number = 1,069)

With candidemia

(number = 38)

P value

SDT

Age, years, mean (SD)

60.0 ± 17.1

59.0 ± 17.9

.706

5.7%

Male/female (%)

67.4/32.6

63.2/36.8

.583

8.8%

APACHE II score at ICU admission, mean (SD)

18.3 ± 7.0

20.1 ± 6.5

.131

-19.24%

SOFA score at ICU admission

7 (4 to 9)

8.5 (7 to 10)

.004

 

ICU length of stay (days)a

17 (12 to 28)

28.5 (16.5 to 53.5)

.001

 

Hospital length of stay (days)a

37 (23 to 59)

37 (26 to 67)

.436

 

ICU mortality, number (%)

220 (20.6)

20 (52.6))

< .001

 

Overall mortality, number (%)

314 (29.6)

21 (55.3)

.001

 

Diagnosis on ICU admission, number (%)

  

.437

 

   Medical

523 (48.9)

16 (42.1)

 

-13.68%

   Surgical

369 (34.5)

17 (44.7)

 

20.97%

   Trauma

177 (16.6)

5 (13.2)

 

-9.55

Multifocal colonization, total, number (%)

649 (60.7)

35 (92.1)

< .001

79.58%

Clinical condition, number (%) at the time of ICU admission

  

< .001

 

   No sepsis

497 (46.6)

1 (2.6)

 

-118.8%

   Sepsis

297 (27.9)

11 (28.9)

 

2.22%

   Severe sepsis

108 (10.1)

11 (28.9)

 

48.84%

   Septic shock

164 (15.4)

15 (39.5)

 

56.1%

Surgery, number (%)

369 (34.4)

17 (44.7)

.202

21.18%

Abdominal surgery, number (%)

205 (19.2)

12 (31.6)

.075

28.78%

Surgical procedures, number

  

.302

 

   None

625 (58.5)

20 (52.6)

 

-11.89%

   One

316 (29.6)

10 (26.3)

 

-7.36%

   Two or more

128 (12.0)

8 (21.1)

 

24.67

Secondary peritonitis, number (%)

65 (6.1)

4 (10.5)

.306

16%

Underlying illnesses, number (%)

    

Neurologic disease

224 (21.0)

5 (13.2)

.220

-20.83%

Trauma

197 (18.4)

7 (18.4)

.999

0%

Diabetes mellitus

183 (17.1)

7 (18.4)

.836

3.4%

COPD

163 (15.2)

9 (23.7)

.183

21.6%

Heart failure

91 (8.5)

6 (15.8)

.155

22.48%

Chronic renal failure

58 (5.4)

2 (5.3)

.965

-0.44%

Acute coronary syndrome

51 (4.8)

1 (2.6)

.507

-11.67%

Chronic liver failure

45 (4.2)

1 (2.6)

.609

-8.84%

Hematologic malignancy

12 (1.1)

0

.359

-14.91%

Solid tumor

124 (11.6)

4 (10.5)

.837

-3.51%

Risk factors, number (%)

    

Urinary catheter

1,057 (99.1)

37 (97.4)

.387

-12.99%

Central venous catheter

1,044 (97.8)

38 (100.0)

.193

21.21%

Mechanical ventilation

967 (90.5)

37 (97.4)

.097

29.24%

Broad-spectrum antibiotics

941 (88.3)

36 (97.3)

.046

35.36%

Empiric/preemptive antifungal treatment.

180 (16.8)

2 (5.3)

.032

-37.31%

Arterial catheter

846 (79.5)

37 (97.4)

.001

58.33%

Enteral nutrition

825 (77.2)

26 (68.4)

.225

-19.87%

Total parenteral nutrition

428 (40.4)

27 (71.1)

< .001

64.99%

Corticosteroids

300 (28.5)

12 (31.6)

.679

6.76%

Renal replacement therapy

126 (12.0)

15 (39.5)

< .001

66.25%

  1. aMedian (25th to 75th percentiles). APACHE, Acute Physiology and Chronic Health Score; COPD, Chronic Obstructive Pulmonary Disease; SD, standard deviation; SDT, standardized difference; SOFA, Sequential Organ Failure Assessment.